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Oxysterols arise from the enzymic or non-enzymic oxidation of cholesterol and have been shown to be cytotoxic to certain cell lines. In particular,
apoptosis induced by the oxysterol 7b-hydroxycholesterol (7b-OH) has been associated with the generation of oxidative stress, cytochrome
c release and caspase activation. Due to the fundamental importance of apoptosis in pathological processes, the identification of substances capable
of modulating this form of cell death is now actively researched. The objective of the present study was to investigate if apigenin, lycopene and
astaxanthin could inhibit 7b-OH-induced apoptosis in U937 cells. Pretreatment with 0·1mM-astaxanthin protected against apoptosis, while lyco-
pene did not oppose the adverse effects of 7b-OH. At low concentrations, apigenin did not protect against oxysterol-induced apoptosis; however, at
higher concentrations it intensified cell death. Additionally, we investigated the effect of 7b-OH, apigenin and astaxanthin on the activation of the
serine threonine kinase Akt (phosphorylated Akt:Akt ratio) to determine whether the effect on cell viability and growth was linked to the Akt
signalling pathway. Akt activation was decreased in the oxysterol-treated cells compared with control cells; however, this did not attain signifi-
cance. Interestingly, activation of Akt was significantly reduced compared with control cells following incubation with apigenin and astaxanthin
both in the absence and in the presence of 7b-OH. Our data suggest that apigenin, lycopene and astaxanthin failed to protect against 7b-OH-
induced apoptosis, and the decrease in cell viability and the increase in apoptotic nuclei induced by the antioxidants appear to be associated
with down regulation of Akt activity.
Akt: Antioxidants: Cytotoxicity: 7b-Hydroxycholesterol
Oxysterols are the oxidation products of cholesterol and
have been shown to possess many potent and diverse bio-
logical activities in vitro. Consequently, oxysterols have
been implicated as possible causes of atherosclerotic lesions
as well as a variety of other diseases. The accumulation of
oxysterols can occur in several different ways, the major
ones being dietary intake (nutritional oxysterols) and internal
chemical and enzymic oxidation(1). Non-enzymic oxidation
occurs primarily on the sterol nucleus, especially at the
7-position and at the 5,6-double bond. These oxysterols,
such as 7b-hydroxycholesterol (7b-OH), which predominates
in early and advanced atherosclerotic lesions(2), are strongly
cytotoxic against the cells of the vascular wall and are
capable of stimulating superoxide anion production(3).
In monocytes/macrophages, oxysterols induce apoptosis by
mechanisms which include a sustained rise in cytosolic
free Ca(4 – 6), activation of Ca-dependent apoptotic and survi-
val pathways(7,8), and induction of oxidative stress(9,10).
Therefore, the inhibition of these processes by supplemen-
tation with antioxidants may be an attractive therapeutic
strategy to prevent and possibly treat atherosclerosis and
related diseases(11).
Flavonoids have diverse pharmacological properties,
including antioxidant, cytoprotective and anti-inflammatory
activities(12). Apigenin is a non-mutagenic flavone found in
a variety of fruits and vegetables including parsley, onions,
wheat sprouts, chamomile, seasonings, tea and orange(13).
Apigenin has gained attention due to its health benefits and
the ability of this compound to chelate metal ions, thereby pre-
venting the formation of reactive oxygen species such as the
hydroxyl radical; this is suggested as one possible mechanism
of cytoprotection(14).
Carotenoids are phytochemicals that are considered to
be beneficial in the prevention of a variety of major
diseases. Lycopene is the most predominant carotenoid in
human plasma and several epidemiological studies have
suggested that high consumption of lycopene-rich foods may
protect against CVD(15,16). Tomatoes and tomato products
( juice, ketchup, soup, sauce) are the major contributors of lyco-
pene in the diet(17), while other rich sources include waterme-
lon, pink grapefruit, pink guava and papaya. The antioxidant
activity of lycopene is highlighted by its singlet oxygen-
quenching property and its ability to trap peroxyl radicals(18).
Another carotenoid, astaxanthin, is commonly found in
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marine animals and is responsible for the pink/red colouration
of crustaceans(19). Within the cell, astaxanthin can effectively
scavenge lipid radicals and destroy peroxide chain reactions,
thereby protecting fatty acids and biological membranes from
oxidative damage. The antioxidant activity of astaxanthin is
claimed to be sevenfold greater than that of a-tocopherol(20).
The aim of the present study was to investigate the effects
of apigenin, lycopene and astaxanthin on 7b-OH-induced
apoptosis in a human monocytic cell line (U937). While
there is considerable evidence that these compounds have
antioxidant potential, there are studies suggesting that caroten-
oids and phenolic phytochemicals with particular structures
exhibit pro-oxidant activity under certain conditions(21,22). In
the present study, a-tocopherol was included as a positive
control as it has previously been shown to protect against
7b-OH-induced cell death in U937 cells(23). U937 cells are
regularly employed as a macrophage reference model in
studies investigating oxysterol-induced cell death(24,25). In
addition, apigenin and astaxanthin in the absence and presence
of 7b-OH on the activation of the serine threonine kinase Akt
was examined using Western blot analysis of the phosphorylated
Akt:Akt ratio. Akt, also known as protein kinase B, regulates
essential cellular functions such as migration, proliferation,
differentiation, apoptosis and metabolism(26). The activation
of the Akt pathway provides cells with a survival signal that
allows them to withstand apoptotic stimuli(27). For instance, it
has recently been reported that carotenoids suppress tissue
factor activity (which plays a key role in vascular thrombosis)
by enhancing phosphorylation of Akt in endothelial cells(28),
while Munteanu et al. (29) found that oxidised LDL-stimulated
Akt phosphorylation in THP-1 monocytes was inhibited by
a-tocopherol. Hence, the purpose of investigating Akt activation
in the present study was two-fold; initially to ascertain whether it
was affected by 7b-OH-induced apoptosis and second, in view
of the importance of Akt in controlling cell survival, to deter-
mine whether the antioxidants in the presence of 7b-OH modu-
late the Akt pathway.
Materials and methods
Materials
All chemicals and cell-culture reagents were obtained from the
Sigma Chemical Co. (Dublin, Republic of Ireland) unless
otherwise stated. Tissue-culture plastics were supplied by
Greiner Bio (Frickenhausen, Germany). Information on the
purity of the 7b-OH (purity . 95 %) was obtained from
Sigma. Western blotting reagents were supplied by Bio-Rad
(Hemel Hempstead, Herts, UK). Cell lines were obtained
from the European Collection of Animal Cell Cultures
(Porton Down, Salisbury, Wilts, UK).
Maintenance of cell lines
Human monocytic U937 cells were grown in suspension in
Roswell Park Memorial Institute (RPMI)-1640 medium sup-
plemented with 10 % (v/v) heat-inactivated fetal bovine
serum supplied by Gibco (Paisley, Renfrewshire, UK). The
cells were grown at 378C in 5 % CO2 in a humidified incuba-
tor. The cells were screened for mycoplasma contamination by
the Hoechst staining method(30) and were cultured in the
absence of antibiotics. Exponentially growing cells were
used throughout.
Treatment of cells with 7b-hydroxycholesterol, a-tocopherol,
apigenin, lycopene and astaxanthin
U937 cells were adjusted to a density of 2 £ 105 cells/ml in
RPMI-1640 medium supplemented with fetal bovine serum
(25 ml/l). Cells were intially pretreated with various concen-
trations of a-tocopherol (10mM), apigenin (0·5–50mM), lyco-
pene or astaxanthin (0·1–1mM) for 1 h followed by treatment
with 30mM-7b-OH. Samples were then incubated for 24 h at
378C in 5 % CO2. Overall, a-tocopherol, apigenin, lycopene
and astaxanthin were in contact with the cells for 25 h.
7b-OH was dissolved in ethanol for delivery to cells and the
final concentration of ethanol in the cultures did not exceed
0·3 % (v/v). a-tocopherol, apigenin, lycopene and astaxanthin
were dissolved in ethanol, dimethyl sulfoxide, hexane and
methylethylketon respectively, where the final concentration
of the solvent in the culture medium was , 0·5 %. Equivalent
quantities of solvent were added to control cells and samples
were incubated for 24 h. For subsequent assays, three concen-
trations of apigenin (5, 10, 50mM) were selected.
Cell viability
Following 24 h incubation, 25ml of cells were removed for
assessment of cell viability. Viability was monitored using a
modification of the fluorochrome-mediated viability assay as
described by Strauss(31). Briefly, cells were mixed 1:1 (v/v)
with a solution of fluorescein diacetate and ethidium bromide,
and then incubated at 378C for 2–5 min before being layered
onto a microscope slide. Under these conditions, live cells
fluoresce green, whereas dead cells fluoresce red. Dying
cells have a green cytoplasm and red nucleus. Samples were
examined at 200 £ magnification on a Nikon fluorescence
microscope using blue light (450–490 nm). Cells (200) were
scored from each slide and cell viability was expressed as
the percentage of viable (green) cells.
Morphological analysis of cell nuclei
Nuclear morphology of control and treated cells was assessed
by fluorescence microscopy after staining with Hoechst
33342. Approximately 4 £ 105 cells were centrifuged at 200 g
for 10 min to form a pellet. Hoechst 33342 stain (200ml; 5mg/
ml) was added and the samples incubated at 378C in 5 % CO2
for 1 h. Stained samples (25ml) were placed on a microscope
slide and examined under UV light (Nikon Labophot fluor-
escence microscope, 400 £ magnification). A total number of
300 cells per sample were analysed and the percentage of frag-
mented and condensed nuclei was calculated. Apoptotic cells
were characterised by nuclear condensation of chromatin and/
or nuclear fragmentation(32).
DNA fragmentation assay
Detection of small DNA fragments was conducted as
described in O’Callaghan et al. (33). Briefly 2 £ 105 cells
were harvested and the pellets were lysed, RNAse A
(0·25 mg/ml) was added and the samples were incubated at
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508C for 1 h. The condensate was spun down and proteinase
K (5 mg/ml) was added. The samples were incubated at
508C for a further 1 h before being loaded into the wells of
a 1·5 % agarose gel. A 100–1500 bp DNA standard (Promega,
Madison, WI, USA) was used to assess DNA fragmentation.
Electrophoresis was carried out in 1·5 % agarose gels prepared
in 2-amino-2-hydroxymethyl-1,3-propanediol (Tris)–borate–
EDTA buffer at 3 V/cm. DNA was visualised under UV
light on a transilluminator (312 nm) following ethidium
bromide staining and photographed using a Bio Imaging
System (GeneGenius, Cambridge, Cambs, UK).
Cell proliferation
Cell proliferation was measured by the 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay using
Cell Proliferation kit I (Roche, Basel, Switzerland) according
to the manufacturer’s instructions. Briefly, 1 £ 105 cells were
treated with 7b-OH, a-tocopherol, apigenin, lycopene and
astaxanthin in the wells of a ninety-six-well costar plate for
24, 48 and 72 h. At the end of the treatment, 10ml MTT
reagent was added. After 4 h incubation at 378C, 100ml of
the solubilisation solution was placed in each well to dissolve
the tetrazolium crystals. Following overnight incubation the
absorbance at 570 nm was recorded using a plate reader.
Western blot analysis
Akt and phosphorylated Akt (Ser473) levels were investigated
by Western blot analysis of cell lysates which had been prein-
cubated with apigenin and astaxanthin and then additionally
exposed to 30mM-7b-OH for 24 h. Cells (5 £ 106) were har-
vested at the end of treatment, washed twice in PBS, and sus-
pended in radioimmunoprecipitation assay (RIPA) buffer
(150 mM-NaCl, 50 mM-Tris-HCl, 0·1 % SDS, 0·5 % sodium
deoxycholate, 1 mM-Na3VO4, 1 mM-NaF) supplemented with
5 % protease inhibitor cocktail (Calbiochem, Nottingham,
Notts, UK). After 30 min incubation at 48C in the lysis
buffer (RIPA) the samples were sonicated. Cell debris was
eliminated by centrifugation at 10 000 g for 30 min and the
supernatant fraction was collected. Protein concentrations
were determined by the bicinchonic assay method. Protein
(20mg) was incubated in loading buffer (0·5 M-Tris-HCl, pH
6·8, 10 % SDS, 10 % glycerol, 0·05 % b-mercaptoethanol
and 0·05 % bromophenol blue) and heated at 1008C for
2 min. Samples were separated by SDS-PAGE and electro-
blotted onto a polyvinylidine difluoride membrane. Mem-
branes were stained with 0·1 % ponceau S solution to ensure
protein loading and transfer was equal. Non-specific binding
sites were blocked by placing the membrane in 5 % non-fat
dry milk in Tris-buffered saline–Tween (0·1 % Tween 20 in
Tris-buffered saline) for 1 h. The membranes were incubated
overnight at 48C with goat monoclonal antibody directed
against Akt 1/2, diluted 1/500 (Santa Cruz Biotechnology,
Inc., Santa Cruz, CA, USA), or a rabbit monoclonal antibody
directed against phosphorylated Akt (Ser473) (Cell Signaling
Technology, Inc., Danvers, MA, USA) diluted 1/1000; all
antibodies were diluted in Tris-buffered saline–Tween. After
three washes in Tris-buffered saline–Tween the membranes
were incubated with appropriate horseradish peroxidase-con-
jugated donkey anti-goat (Santa Cruz Biotechnology) or
anti-rabbit (Cell Signaling Technology) for 1 h at room tem-
perature. Following washing, immunoreactive bands were
visualised using an enhanced chemiluminescence detection
kit (Perkin Elmer, Waltham, MA, USA) and subsequent
exposure to autoradiography film. The bands were identified
according to their migration value. Quantification of results
was performed by densitometry (GeneGenius gel documen-
tation and analysis system; Syngene, Cambridge, Cambs,
UK), quantifying the density of identically sized areas (corres-
ponding to immunoreactive bands) and results analysed as
total integrated densitometric volume values (arbitrary
units). Results are reported as mean values with their standard
errors. Both Akt and phosphorylated Akt (Ser473) antibody
immunoreactivities were tested to ensure that immunoreactiv-
ity measured was linear with increasing protein concentration.
Statistics
All data points are the mean values with their standard errors
of at least three independent experiments. Where appropriate,
data were analysed by one-way ANOVA. The software
employed for statistical analysis was GraphPad Prism (version
4; GraphPad Software, San Diego, CA, USA).
Results
Effect of apigenin, lycopene and astaxanthin on
7b-hydroxycholesterol-induced toxicity
U937 cells were exposed simultaneously to 30mM-7b-OH and
increasing concentrations of apigenin, lycopene and astax-
anthin (Tables 1–3). Following 24 h incubation, samples
were counted and stained with either fluorescein diacetate or
ethidium bromide to assess membrane integrity or Hoechst
33342 to examine nuclear morphology. Viability in the control
samples was above 95 % in all experiments. Treatment of
Table 1. Effect of apigenin on 7b-hydroxycholesterol (7b-OH)-induced
cytotoxicity†
(Mean values with their standard errors of three independent experi-
ments)
% Viable cells
% Apoptotic
nuclei
Treatment Mean SE Mean SE
Control 97·5*** 0·5 3·8 1·0
30mM-7b-OH 70·3 2·2 18·0 1·3
5mM-Apigenin 98·8*** 0·4 5·5 1·1
10mM-Apigenin 94·3*** 1·1 10·7 1·5
50mM-Apigenin 11·7*** 1·8 74·4*** 3·7
30mM-7b-OH þ
10mM-a-tocopherol
83·9* 2·1 11·7 1·3
30mM-7b-OH þ 0·5mM-apigenin 65·8 4·9 15·9 1·5
30mM-7b-OH þ 2mM-apigenin 79·7 4·2 15·6 1·6
30mM-7b-OH þ 5mM-apigenin 82·2 2·3 15·0 2·2
30mM-7b-OH þ 10mM-apigenin 69·8 0·9 24·9 5·8
30mM-7b-OH þ 50mM-apigenin 27·8*** 4·1 57·1*** 11·2
Mean value was significantly different from that for the 30mM-7b-OH treatment:
*P,0·05, ***P,0·001 (ANOVA followed by the Bonferroni test).
† U937 cells were treated with 0·5, 2, 5, 10 and 50mM-apigenin, over 24 h, in the
presence or absence of 30mM-7b-OH. Samples were processed for either cell
viability or stained with Hoechst 33342 and analysed by fluorescence
microscopy.
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U937 cells with 7b-OH decreased viability to approximately
68 % and increased the number of apoptotic nuclei. With the
exception of 50mM-apigenin (Table 1) and 1mM-astaxanthin
(Table 3), none of the compounds tested was found to be
toxic to the cells. The antioxidant a-tocopherol has previously
been shown to decrease the toxicity of 7b-OH to U937
cells(23). Similarly, in the present study, 10mM-a-tocopherol
significantly (P,0·05) increased the viability and decreased
the apoptotic death of cells exposed to the oxysterol. In the
presence of 7b-OH, the lower concentrations of apigenin did
not significantly alter cell viability; however, the flavonoid
at 50mM potentiated cell death (Table 1). Exposure to lyco-
pene for 24 h did not oppose the adverse effects of 7b-OH
in U937 cells (Table 2). Pretreatment with 0·1mM-astaxanthin
significantly (P,0·01) protected against 7b-OH-induced
apoptosis while the higher concentration (1mM) appeared to
potentiate the toxicity of the oxysterol (Table 3). Cell death
by apoptosis was confirmed by the DNA fragmentation
assay (Fig. 1). A ladder-like pattern was observed following
24 h exposure to apigenin, lycopene and astaxanthin in the
presence of 30mM-7b-OH. Treatment with a-tocopherol
visibly reduced DNA laddering produced by the oxysterol,
confirming a protective effect.
Cell proliferation
7b-OH-induced cytotoxicity was further investigated by the
measurement of cell proliferation over 72 h. The absorbance
of formazan crystals liberated over time from MTT labelling
reagent was used to assess U937 cell growth. Following 24,
48 and 72 h incubation, 30mM-7b-OH caused a significant
(P,0·001) delay in cell proliferation relative to the control.
Pretreatment with a-tocopherol did not protect against the
decrease in cell proliferation. As shown in Fig. 2, apigenin
did not provide any protection against the decline in cell
growth over 72 h. In addition, 10mM-apigenin alone signifi-
cantly (P,0·001) inhibited U937 cell proliferation; however,
this was suppressed even further in the presence of the oxy-
sterol. As expected, 50mM-apigenin significantly (P,0·001)
decreased cell growth both in the absence and in the presence
of 7b-OH.
In the absence of the oxysterol, lycopene had no effect on
cell proliferation and it did not protect against the suppressed
cell growth induced by 7b-OH (Fig. 3). At the 48 (P,0·05)
and 72 h (P,0·01) time points, 1mM-astaxanthin significantly
inhibited proliferation of U937 cells but not to the same extent
as 7b-OH (Fig. 4). Similar to lycopene, astaxanthin did not
protect against the oxysterol-induced decrease in cell growth
at any of the concentrations tested.
MW 1 2 3 4 5 6 7 8 9
Fig. 1. Induction of DNA fragmentation in U937 cells at 24 h. DNA was
isolated and electrophoresed in 1·5 % gels (3 V/cm) as described in Materials
and methods. After staining with ethidium bromide, gels were visualised
under UV light on a transilluminator (312 nm) and photographed using a Bio
Imaging System (GeneGenius, Cambridge, Cambs, UK). Lane 1, control;
lane 2, 30mM-7b-OH; lane 3, 30mM-7b-OH þ 10mM-a-tocopherol; lane 4,
50mM-apigenin; lane 5, 30mM-7b-OH þ 50mM-apigenin; lane 6, 1mM-lyco-
pene; lane 7, 30mM-7b-OH þ 1mM-lycopene; lane 8, 1mM-astaxanthin;
lane 9, 30mM-7b-OH þ 1mM-astaxanthin. MW, molecular weight marker.
Table 2. Effect of lycopene on 7b-hydroxycholesterol (7b-OH)-induced
cytotoxicity†
(Mean values with their standard errors of three independent experi-
ments)
% Viable
cells
% Apoptotic
nuclei
Treatment Mean SE Mean SE
Control 96·5*** 0·8 4·4** 0·3
30mM-7b-OH 67·2 2·7 12·5 1·6
0·1mM-Lycopene 97·2*** 0·8 6·5 1·2
0·5mM-Lycopene 94·1*** 2·0 7·5 0·8
1mM-Lycopene 95·5*** 2·0 8·4 0·7
30mM-7b-OH þ 10mM-a-tocopherol 85·7* 4·6 7·4 1·3
30mM-7b-OH þ 0·1mM-lycopene 72·3 2·9 12·5 1·4
30mM-7b-OH þ 0·5mM-lycopene 64·7 6·4 13·0 0·5
30mM-7b-OH þ 1mM-lycopene 65·9 3·3 15·6 2·0
Mean value was significantly different from that for the 30mM-7b-OH treatment:
*P,0·05, **P,0·01, ***P,0·001 (ANOVA followed by the Bonferroni test).
† U937 cells were treated with 0·1, 0·5 and 1mM-lycopene, over 24 h, in the pre-
sence or absence of 30mM-7b-OH. Samples were processed for either cell viabi-
lity or stained with Hoechst 33342 and analysed by fluorescence microscopy.
Table 3. Effect of astaxanthin on 7b-hydroxycholesterol (7b-OH)-
induced cytotoxicity†
(Mean values with their standard errors of three independent experi-
ments)
% Viable
cells
% Apoptotic
nuclei
Treatment Mean SE Mean SE
Control 96·2** 0·9 4·9*** 2·1
30mM-7b-OH 67·9 6·8 22·0 2·9
0·1mM-Astaxanthin 92·6* 2·0 4·9*** 0·8
0·5mM-Astaxanthin 89·8* 4·6 7·0*** 1·2
1mM-Astaxanthin 74·8 5·4 15·0 2·2
30mM-7b-OH þ 10mM-a-tocopherol 92·3* 1·7 8·3*** 0·5
30mM-7b-OH þ 0·1mM-astaxanthin 88·2 0·3 9·9** 2·4
30mM-7b-OH þ 0·5mM-astaxanthin 79·2 2·2 15·9 0·2
30mM-7b-OH þ 1mM-astaxanthin 50·8 7·4 48·6*** 1·7
Mean value was significantly different from that for the 30mM-7b-OH treatment:
*P,0·05, **P,0·01, ***P,0·001 (ANOVA followed by the Bonferroni test).
† U937 cells were treated with 0·1, 0·5 and 1mM-astaxanthin, over 24 h, in the pre-
sence or absence of 30mM-7b-OH. Samples were processed for either cell viabi-
lity or stained with Hoechst 33342 and analysed by fluorescence microscopy.
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Akt levels and Akt activation
Western blotting was employed to investigate the effect of
7b-OH, apigenin and astaxanthin on Akt activation and to
determine whether the effects of these agents on cell viability
and growth was linked mechanistically to this signalling path-
way. Akt activation is commonly measured using the ratio of
phosphorylated active Akt:total Akt(34). In the oxysterol-trea-
ted cells the ratio of phosphorylated Akt:total Akt was
reduced, thus Akt activity was reduced; however, this did
not attain significance (Fig. 5). Interestingly, activation of
Akt was significantly reduced compared with control and
7b-OH-treated levels following incubation with apigenin
(10mM) and astaxanthin (1mM). Moreover, this reduction in
Akt activation was also observed when the cells were treated
with these concentrations of apigenin and astaxanthin alone.
Discussion
The oxysterol 7b-OH has been shown to induce oxidative
stress in U937 cells, leading to apoptotic cell death(9,10,35,36).
Due to the fundamental importance of apoptosis in pathologi-
cal processes, the identification of substances capable of
modulating this form of cell death is now actively researched.
On the basis of experimental evidence that flavonoids and
carotenoids are antioxidants and have the ability to scavenge
free radicals, we examined the effects of apigenin, lycopene
and astaxanthin on 7b-OH-induced cytotoxicity.
The data presented in the present report confirm that
7b-OH induces apoptosis in human monocytic U937 cells.
In addition, our findings show that apigenin, lycopene
and astaxanthin provide little or no protection against
7b-OH-induced apoptosis. Following 24 h incubation with
7b-OH, lower concentrations of apigenin did not protect
against the decrease in cell viability or proliferation, while
at 50mM, it intensified cell death. These results are compar-
able with a study conducted by Wang et al. (37) in which the
effects of four structurally related flavonoids on HL-60 cell
viability were investigated. Following 12 h treatment, api-
genin appeared to be more potent, with a half-maximal
inhibitory concentration (IC50) of 50mM and dose-dependent
inhibition of cell viability. Also, DNA fragmentation only
became apparent with between 20 and 40mM-apigenin treat-
ment, and the induction of caspase-3 activity by apigenin par-
alleled this pattern.
Carotenoids have been suggested to be protective against
coronary vascular disease. Before the present study, the effects
of lycopene and astaxanthin on oxysterol-induced apoptosis
Fig. 2. Effect of apigenin (apig) on cell proliferation. U937 cells were treated with 5, 10 and 50mM-apig in the presence or absence of 30mM-7b-OH, for 24 ( ), 48
( ) and 72 ( ) h. Values are means of three independent experiments, with their standard errors represented by vertical bars. toc, Tocopherol.
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had not been investigated. Lycopene is one of the most potent
antioxidants among the dietary carotenoids and may help
lower the risk of chronic diseases including cancer and heart
disease(18). However, none of the concentrations of lycopene
employed in the present study protected against the increase
in apoptotic nuclei or the decrease in cell growth in 7b-OH-
treated cells. The present results also showed that pretreatment
with 0·1mM-astaxanthin significantly (P,0·01) protected
against 7b-OH-induced apoptosis whereas the carotenoid at
1mM exaggerated the toxicity of the oxysterol. A study
involving Watanabe heritable hyperlipidaemic rabbits evaluat-
ing the possible anti-atherosclerotic effect of a-tocopherol
and astaxanthin found that both antioxidants improved
plaque stability and significantly diminished apoptosis(38).
Overall, astaxanthin may possess some protective properties
relative to oxysterol-induced apoptosis but only at low
concentrations.
The generation of oxidative stress has been implicated in
the earlier stages of apoptosis induced by certain oxysterols.
Ryan et al. (9) demonstrated that in 7b-OH-induced apoptosis,
in U937 cells, glutathione levels began to decrease after 6 h
coupled with an increase in superoxide dismutase activity.
However, no evidence of apoptosis was reported after 6 h.
The reduced levels of glutathione within the cell did not
appear to alter between the 6 h and the 24 h time point and
the superoxide dismutase activity was not significantly
increased following 24 h treatment with the oxysterol. In
addition, O’Callaghan et al. (39) observed that there was no
significant change in the activity of the catalase enzyme in
U937 cells following a 12 h incubation in the presence of
7b-OH. The results observed in the present study, along
with numerous other studies(40 – 44), have shown that several
compounds with proven antioxidant properties do not protect
against oxysterol-induced cell death. Taken together, these
results suggest that although oxidative stress may be an
initiator of 7b-OH-induced apoptosis, it is not completely
responsible for the induction of cell death.
7b-OH is present at enhanced levels in atherosclerotic pla-
ques and is believed to play a key role in atherogenesis. As
apoptosis of vascular cells occurring in atherosclerotic plaques
is believed to promote thrombotic events and plaque rupture it
is of interest to determine the mechanisms of cell death trig-
gered by these oxysterols(7). Akt has been well characterised
as an anti-apoptotic kinase that transduces cellular survival sig-
nals in many cell types(45). A previous study demonstrated that,
in the murine macrophage-like cell line P388D1, oxysterols
(25-hydroxycholesterol and 7-ketocholesterol) induced the
degradation of Akt(46). To determine whether 7b-OH-induced
apoptosis could also induce Akt degradation or effect Akt acti-
vation, we examined the levels of both total Akt and active
Fig. 3. Effect of lycopene (lyco) on cell proliferation. U937 cells were treated with 0·1, 0·5 and 1mM-lyco in the presence or absence of 30mM-7b-OH, for 24 ( ),
48 ( ) and 72 ( ) h. Values are means of three independent experiments, with their standard errors represented by vertical bars. toc, Tocopherol.
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phosphorylated Ser473 Akt in U937 cells. The ratio of
phosphorylated Akt:total Akt was reduced in the oxysterol-
treated cells. However, this did not attain significance and,
unlike the previous study(46), total Akt levels were unchanged
in the presence of 7b-OH. In addition, it was found that concen-
trations of apigenin (10mM) and astaxanthin (1mM) that
decrease cell proliferation and viability also significantly
decreased Akt activation without significantly affecting Akt
levels, with this effect remaining the same when using the com-
bination of the antioxidant plus the oxysterol. These results
suggest that the anti-proliferative effects of these antioxidants
may be mechanistically linked to the inhibition of Akt, and
occur in the absence and presence of the oxysterol. In agree-
ment with this Way et al. (47) have reported that apigenin inhi-
bits Akt phosphorylation at serine 473 in three breast cancer
cell lines. They found that apigenin directly inhibited PI3K
activity, an upstream mediator of Akt, and indirectly caused
an inhibitory effect on Akt kinase activity. Following on
from this study, it was found that apigenin induced apoptosis
through cytochrome c release with subsequent activation of
caspase-3(48). Therefore it appears that the antioxidant, alone
or together with the oxysterol, but not the oxysterol alone,
greatly inhibits Akt signalling. Palozza et al. (49) have recently
found that Akt was down regulated in THP-1 cells in response
to treatment with 7-ketocholesterol for 24 h and this effect was
completely reverted by the addition of b-carotene. The authors
maintain that the carotenoid may be altering redox-sensitive
molecular pathways involved in the control of cell proliferation
and apoptosis and, consequently, by acting as a possible
anti-atherogenic agent. In contrast, our data suggest that api-
genin and astaxanthin at the concentrations tested provide no
benefit in the treatment of atherosclerosis as their induction
of apoptosis is significantly involved in the down regulation
of the Akt pathway.
Although the present study focuses on the protective
potential of antioxidants against oxysterol-induced apoptosis
and atherosclerosis, the negative effects observed following
treatment with high concentrations of apigenin and astax-
anthin could also be looked at from a chemotherapeutic per-
spective. Some dietary components modulate cell signalling
pathways, among other mechanisms, which activate cell
death signals and induce apoptosis in precancerous or
cancer cells, resulting in the inhibition of cancer development
and/or progression(50). Numerous studies have reported
that apigenin may serve as a chemotherapeutic agent because
of its ability to inhibit cell proliferation and induce apoptosis
in cancer cells(37,47,48,51 – 53). Additionally, Tanaka et al. (54 – 56)
have shown that oral administration of astaxanthin inhibits
Fig. 4. Effect of astaxanthin (asta) on cell proliferation. U937 cells were treated with 0·1, 0·5 and 1mM-asta in the presence or absence of 30mM-7b-OH, for 24
( ), 48 ( ) and 72 ( ) h. Values are means of three independent experiments, with their standard errors represented by vertical bars. toc, Tocopherol.
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carcinogenesis in mice urinary bladder, in the oral cavity and
rat colon. This effect has been partially attributed to suppres-
sion of cell proliferation. Moreover, epidemiological data
provide evidence concerning the health benefits of these com-
pounds in the development of cancer. De Stefani et al. (57)
analysed dietary data from 541 individuals with lung cancer
and 540 hospitalised controls and reported significant
inverse associations with increasing carotenoid, glutathione,
flavonoid and vitamin E intake. Overall, the present
results demonstrate the pro-apoptotic properties of apigenin
and astaxanthin that could support their potential use as che-
mopreventive and therapeutic agents against carcinogenic
disease.
In conclusion, as apigenin, lycopene and high concen-
trations of astaxanthin failed to protect against 7b-OH-
induced apoptosis we present evidence that the initial
oxidative stress generated by the oxysterol may concede to
other apoptotic events. Studies have shown that the apoptotic
process induced by 7b-OH is associated with generation of
reactive oxygen species, followed by permeabilisation of lyso-
somal and mitochondrial membranes, Bcl-xL degradation,
activation of caspase-9 and caspase-3, ultimately leading to
degradation of poly(ADP-ribose) polymerase(3,9,35,39). We
have also shown that, while 7b-OH does not have a consider-
able effect on Akt, however, apigenin or astaxanthin alone or
combining them with the oxysterol inhibits Akt activation in
U937 cells.
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